Delivery Order HHSN271201600006I-75N95020F00002
- This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract, valued at $11,883,375.62, was awarded on December 15, 2002 to Sri International, a non-profit research and development institute, for the purpose of de-obligating FY2006 funds. The contract has a period of performance through December 31, 2009 and is being performed in West Menlo Park, CA. Sri...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development organization. The contract is an administrative task order under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery vehicle (IDV). The total ceiling value of this award is $106,072.00, and the period of performance is from September 13, 2015 to September 12, 2016. The contract is a...
- This federal contract award is for "FOLLOW-ON 28 DAY DOG PHARMACOKINETIC AND CLINICAL CHEMISTRY ASSESSMENTS" and was issued by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Sri International, a non-profit research institute. The contract is a Delivery Order under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a potential...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River...
- This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to SRI International, a non-profit research institute, for the Pharmacology and Toxicology for Therapeutics Program (PTTP). The $489,875.00 contract is a Delivery Order under the PTTP Indefinite Delivery Vehicle (IDV), which allows SRI to provide research, development, and advisory services to HHS/NIH on an as-needed basis. SRI...
- This federal contract award is an Indefinite Delivery/Indefinite Quantity (IDIQ) parent award for the Pharmacology and Toxicology for Therapeutics Program (PTTP) administered by the National Institute on Drug Abuse, a civilian agency. The contract was awarded to SRI International, a non-profit research and development institute, and does not have a set-aside designation. The purpose of this award is to de-obligate unexpended and expiring Fiscal Year 2020 funding in preparation for the...
- This is a $756,613.00 firm fixed-price delivery order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services (HHS), to Sri International, a non-profit research and development institute. The award is for Task Order #001 under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master indefinite delivery/indefinite quantity (IDIQ) contract, and covers management and operations support...
- This is a cost-plus-fixed-fee delivery order task order awarded by the Department of Health and Human Services' National Institute on Drug Abuse (NIDA) to nonprofit research institute SRI International. The contract, valued at $479,933.60, is for toxicological evaluations of potential medications over a period of performance from September 7, 2018 to September 6, 2023. SRI International has extensive experience providing research, engineering, and technical services to federal agencies such as...
- This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...
- Sri International has been awarded a $4.5 million delivery order against the Department of Health and Human Services Program Support Center's multiple award IDIQ contract vehicle. The delivery order is for NAID/NIH preclinical drug development expertise and will be performed over a five year period ending in December 2023. Sri International will provide preclinical drug development services to the National Institute of Allergy and Infectious Diseases and the National Institutes of Health. Work...
- HHSN271201600006IIndefinite Delivery Contract
- HHSN271201600006I-75N95020F00002Delivery Order
Sri International, a non-profit research and development organization headquartered in Menlo Park, California, was awarded a parent Indefinite Delivery Indefinite Quantity (IDIQ) contract by the National Institute on Drug Abuse (NIDA) under the Pharmacology and Toxicology for Therapeutics Program (PTTP). This delivery order contract, valued at approximately $419K with a cost-plus-fixed-fee pricing structure, was awarded on September 15, 2020, with an ultimate completion date of September 17, 2021. The contract does not carry a small business set-aside designation. Work will be performed at Sri International's facility in Menlo Park, California. As the parent IDIQ vehicle for the PTTP, this contract establishes the framework through which NIDA can issue task orders for pharmacology and toxicology research services supporting the agency's therapeutic development initiatives. Sri International's multidisciplinary research capabilities position it to support NIDA's mission of advancing drug abuse prevention and treatment through scientific investigation. The IDIQ structure provides NIDA with flexible access to Sri International's specialized expertise in safety evaluation and toxicology studies, enabling rapid procurement of research services across multiple scientific investigations related to drug therapeutics and related pharmacological research.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmacology and Toxicology for Therapeutics Program (PTTP) | NIH-NINDS-16-01 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/4/16, 3:43 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($7k) | 9/17/25 | |
| Not listed | Not listed | $137.8k | 9/15/20 |